Skip to main content
PMC home page
Antimicrobial Agents and Chemotherapy logoLink to Antimicrobial Agents and Chemotherapy
. 1995 Sep;39(9):1984–1987. doi: 10.1128/aac.39.9.1984

Synergistic effect of amoxicillin and cefotaxime against Enterococcus faecalis.

J L Mainardi 1, L Gutmann 1, J F Acar 1, F W Goldstein 1
PMCID: PMC162868  PMID: 8540703

Abstract

The antibacterial efficacy of the combination of amoxicillin and cefotaxime was assessed against 50 clinical strains of Enterococcus faecalis. For 48 of 50 strains, the MIC of amoxicillin that inhibited 50% of isolates tested decreased from 0.5 microgram/ml (range, 0.25 to 1 microgram/ml) to 0.06 microgram/ml (range, 0.01 to 0.25 microgram/ml) in the presence of only 4 micrograms of cefotaxime per ml. Alternatively, the MIC of cefotaxime that inhibited 50% of isolates tested decreased from 256 micrograms/ml (range, 8 to 512 micrograms/ml) to 1 micrograms/ml (range, 0.5 to 16 micrograms/ml) in the presence of only 0.06 microgram of amoxicillin per ml. For JH2-2, a reference strain of E. faecalis, the MICs of amoxicillin, cefotaxime, and amoxicillin in the presence of cefotaxime (4 micrograms/ml) were 0.5, 512, and 0.06 microgram/ml, respectively. By using a penicillin-binding protein (PBP) competition assay, it was shown that with cefotaxime, 50% saturation of PBPs 2 and 3 was obtained at very low concentrations (< 1 microgram/ml), while 50% saturation of PBPs 1, 4, and 5 was obtained with > or = 128 micrograms/ml. With amoxicillin, 50% saturation of PBPs 4 and 5 was obtained at 0.12 and 0.5 microgram/ml, respectively. Therefore, the partial saturation of PBPs 4 and 5 by amoxicillin combined with the total saturation of PBPs 2 and 3 by cefotaxime could be responsible for the observed synergy between these two compounds.

Full Text

The Full Text of this article is available as a PDF (401.7 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Canepari P., Lleò M. M., Fontana R., Satta G. Streptococcus faecium mutants that are temperature sensitive for cell growth and show alterations in penicillin-binding proteins. J Bacteriol. 1987 Jun;169(6):2432–2439. doi: 10.1128/jb.169.6.2432-2439.1987. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Craig W. A., Ebert S. C. Continuous infusion of beta-lactam antibiotics. Antimicrob Agents Chemother. 1992 Dec;36(12):2577–2583. doi: 10.1128/aac.36.12.2577. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Felmingham D., Wilson A. P., Quintana A. I., Grüneberg R. N. Enterococcus species in urinary tract infection. Clin Infect Dis. 1992 Aug;15(2):295–301. doi: 10.1093/clinids/15.2.295. [DOI] [PubMed] [Google Scholar]
  4. Fontana R., Grossato A., Ligozzi M., Tonin E. A. In vitro response to bactericidal activity of cell wall-active antibiotics does not support the general opinion that enterococci are naturally tolerant to these antibiotics. Antimicrob Agents Chemother. 1990 Aug;34(8):1518–1522. doi: 10.1128/aac.34.8.1518. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Frieden T. R., Munsiff S. S., Low D. E., Willey B. M., Williams G., Faur Y., Eisner W., Warren S., Kreiswirth B. Emergence of vancomycin-resistant enterococci in New York City. Lancet. 1993 Jul 10;342(8863):76–79. doi: 10.1016/0140-6736(93)91285-t. [DOI] [PubMed] [Google Scholar]
  6. Handwerger S., Perlman D. C., Altarac D., McAuliffe V. Concomitant high-level vancomycin and penicillin resistance in clinical isolates of enterococci. Clin Infect Dis. 1992 Mar;14(3):655–661. doi: 10.1093/clinids/14.3.655. [DOI] [PubMed] [Google Scholar]
  7. Handwerger S., Raucher B., Altarac D., Monka J., Marchione S., Singh K. V., Murray B. E., Wolff J., Walters B. Nosocomial outbreak due to Enterococcus faecium highly resistant to vancomycin, penicillin, and gentamicin. Clin Infect Dis. 1993 Jun;16(6):750–755. doi: 10.1093/clind/16.6.750. [DOI] [PubMed] [Google Scholar]
  8. Hodges T. L., Zighelboim-Daum S., Eliopoulos G. M., Wennersten C., Moellering R. C., Jr Antimicrobial susceptibility changes in Enterococcus faecalis following various penicillin exposure regimens. Antimicrob Agents Chemother. 1992 Jan;36(1):121–125. doi: 10.1128/aac.36.1.121. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Jacob A. E., Hobbs S. J. Conjugal transfer of plasmid-borne multiple antibiotic resistance in Streptococcus faecalis var. zymogenes. J Bacteriol. 1974 Feb;117(2):360–372. doi: 10.1128/jb.117.2.360-372.1974. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Johnson A. P., Uttley A. H., Woodford N., George R. C. Resistance to vancomycin and teicoplanin: an emerging clinical problem. Clin Microbiol Rev. 1990 Jul;3(3):280–291. doi: 10.1128/cmr.3.3.280. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Schaberg D. R., Culver D. H., Gaynes R. P. Major trends in the microbial etiology of nosocomial infection. Am J Med. 1991 Sep 16;91(3B):72S–75S. doi: 10.1016/0002-9343(91)90346-y. [DOI] [PubMed] [Google Scholar]
  12. Uttley A. H., George R. C., Naidoo J., Woodford N., Johnson A. P., Collins C. H., Morrison D., Gilfillan A. J., Fitch L. E., Heptonstall J. High-level vancomycin-resistant enterococci causing hospital infections. Epidemiol Infect. 1989 Aug;103(1):173–181. doi: 10.1017/s0950268800030478. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Williamson R., Calderwood S. B., Moellering R. C., Jr, Tomasz A. Studies on the mechanism of intrinsic resistance to beta-lactam antibiotics in group D streptococci. J Gen Microbiol. 1983 Mar;129(3):813–822. doi: 10.1099/00221287-129-3-813. [DOI] [PubMed] [Google Scholar]
  14. Williamson R., Gutmann L., Horaud T., Delbos F., Acar J. F. Use of penicillin-binding proteins for the identification of enterococci. J Gen Microbiol. 1986 Jul;132(7):1929–1937. doi: 10.1099/00221287-132-7-1929. [DOI] [PubMed] [Google Scholar]
  15. Zervos M. J., Kauffman C. A., Therasse P. M., Bergman A. G., Mikesell T. S., Schaberg D. R. Nosocomial infection by gentamicin-resistant Streptococcus faecalis. An epidemiologic study. Ann Intern Med. 1987 May;106(5):687–691. doi: 10.7326/0003-4819-106-5-687. [DOI] [PubMed] [Google Scholar]
  16. al-Obeid S., Gutmann L., Williamson R. Correlation of penicillin-induced lysis of Enterococcus faecium with saturation of essential penicillin-binding proteins and release of lipoteichoic acid. Antimicrob Agents Chemother. 1990 Oct;34(10):1901–1907. doi: 10.1128/aac.34.10.1901. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. al-Obeid S., Gutmann L., Williamson R. Modification of penicillin-binding proteins of penicillin-resistant mutants of different species of enterococci. J Antimicrob Chemother. 1990 Nov;26(5):613–618. doi: 10.1093/jac/26.5.613. [DOI] [PubMed] [Google Scholar]

Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES